See more : Xcorporeal, Inc. (XCRP) Income Statement Analysis – Financial Results
Complete financial analysis of KP Tissue Inc. (KPT.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of KP Tissue Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Mitsubishi Motors Corporation (MMTOF) Income Statement Analysis – Financial Results
- Regional Health Properties, Inc. (RHE-PA) Income Statement Analysis – Financial Results
- Gujarat Natural Resources Limited (GNRL.BO) Income Statement Analysis – Financial Results
- Tokyo Steel Manufacturing Co., Ltd. (5423.T) Income Statement Analysis – Financial Results
- Toyo Ink SC Holdings Co., Ltd. (4634.T) Income Statement Analysis – Financial Results
KP Tissue Inc. (KPT.TO)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.kptissueinc.com
About KP Tissue Inc.
KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins, as well as manufactures private label tissue products. The company markets its products under the Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, White Swan, and Metro brand names. The company sells its products to consumers through traditional retail channels, such as grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers; and through distributors to businesses involved in commercial users in the property management, healthcare, food services, manufacturing, lodging industries, and public facilities. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 830.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | -12.55M | -321.00K | -634.00K | 574.00K | 196.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 830.00K | -12.55M | -321.00K | -634.00K | 574.00K | 196.00K | 3.25M | 67.00K | 33.41M | 2.28M | 1.73M | 3.96K |
| Cost & Expenses | 830.00K | -12.55M | -321.00K | -634.00K | 574.00K | 196.00K | 3.25M | 67.00K | 33.41M | 2.28M | 1.73M | 3.96K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 238.61M | 115.99M | 153.43M | 197.84M | 145.04M | -1.78M | 52.52K | 22.82K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 238.61M | 752.00K | 153.43M | 197.84M | 145.04M | -196.00K | 190.00K | 0.00 | -27.93M | -2.28M | 615.00K | -2.77K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Operating Income | 0.00 | -12.55M | -321.00K | -634.00K | -574.00K | 1.59M | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | -2.77K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Total Other Income/Expenses | -830.00K | -12.55M | 1.76M | 474.00K | -4.80M | 1.59M | 3.25M | 67.00K | 0.00 | 0.00 | 1.73M | -3.96K |
| Income Before Tax | -830.00K | -12.55M | 1.12M | -794.00K | -4.80M | 1.59M | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | -3.96K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Income Tax Expense | 4.11M | -2.30M | -118.00K | 1.16M | 1.73M | 1.76M | 2.19M | 1.79M | -2.07M | 241.00K | 2.01M | 592.00 |
| Net Income | -4.94M | -10.25M | 1.24M | -1.95M | -6.53M | -173.00K | -5.44M | -1.72M | -31.34M | -2.52M | -285.00K | -3.36K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 167.42% | -2,570.15% | 93.82% | 110.58% | -16.49% | 0.00% |
| EPS | -0.50 | -1.03 | 0.13 | -0.20 | -0.68 | -0.02 | -0.59 | -0.19 | -3.52 | -0.29 | -0.03 | 0.00 |
| EPS Diluted | -0.50 | -1.03 | 0.13 | -0.20 | -0.68 | -0.02 | -0.59 | -0.19 | -3.52 | -0.29 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 9.96M | 9.94M | 9.84M | 9.70M | 9.54M | 9.32M | 9.16M | 9.04M | 8.91M | 8.83M | 8.75M | 8.00M |
| Weighted Avg Shares Out (Dil) | 9.96M | 9.94M | 9.84M | 9.70M | 9.54M | 9.32M | 9.16M | 9.04M | 8.91M | 8.83M | 8.75M | 8.00M |
Source: https://incomestatements.info
Category: Stock Reports